• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性呼吸窘迫综合征的预防

Prevention of acute respiratory distress syndrome.

作者信息

Festic Emir, Kor Daryl J, Gajic Ognjen

机构信息

aPulmonary and Critical Care Medicine, Mayo Clinic, Jacksonville, Florida bAnesthesiology and Critical Care Medicine cPulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Curr Opin Crit Care. 2015 Feb;21(1):82-90. doi: 10.1097/MCC.0000000000000174.

DOI:10.1097/MCC.0000000000000174
PMID:25501020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4431656/
Abstract

PURPOSE OF REVIEW

The paucity of effective therapeutic interventions in patients with the acute respiratory distress syndrome (ARDS) combined with overwhelming evidence on the importance of timely implementation of effective therapies to critically ill patients has resulted in a recent shift in ARDS research. Increasingly, efforts are being directed toward early identification of patients at risk with a goal of prevention and early treatment, prior to development of the fully established syndrome. The focus of the present review is on the prevention of ARDS in patients without this condition at the time of their healthcare encounter.

RECENT FINDINGS

The primary thematic categories presented in the present review article include early identification of patients at risk of developing ARDS, optimization of care delivery and its impact on the incidence of ARDS, pharmacological prevention of ARDS, prevention of postoperative ARDS, and challenges and opportunities with ARDS prevention studies.

SUMMARY

Recent improvements in clinical care delivery have been associated with a decrease in the incidence of hospital-acquired ARDS. Despite the initial challenges, research in ARDS prevention has become increasingly feasible with several randomized controlled trials on ARDS prevention completed or on the way.

摘要

综述目的

急性呼吸窘迫综合征(ARDS)患者有效的治疗干预措施匮乏,加之有大量证据表明对危重症患者及时实施有效治疗非常重要,这导致近期ARDS研究出现了转变。越来越多的努力旨在早期识别有风险的患者,目标是在完全发展成该综合征之前进行预防和早期治疗。本综述的重点是在医疗接触时没有这种病症的患者中预防ARDS。

最新发现

本综述文章中呈现的主要主题类别包括早期识别有发生ARDS风险的患者、优化护理提供及其对ARDS发病率的影响、ARDS的药物预防、术后ARDS的预防以及ARDS预防研究的挑战与机遇。

总结

临床护理提供方面最近的改善与医院获得性ARDS发病率的降低有关。尽管最初存在挑战,但随着几项关于ARDS预防的随机对照试验已经完成或正在进行,ARDS预防研究已变得越来越可行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/b8c39a0f4923/nihms649783f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/c0a2810ae76d/nihms649783f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/28e36aa7cd3c/nihms649783f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/0bc450e69261/nihms649783f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/b8c39a0f4923/nihms649783f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/c0a2810ae76d/nihms649783f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/28e36aa7cd3c/nihms649783f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/0bc450e69261/nihms649783f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0fb/4431656/b8c39a0f4923/nihms649783f4.jpg

相似文献

1
Prevention of acute respiratory distress syndrome.急性呼吸窘迫综合征的预防
Curr Opin Crit Care. 2015 Feb;21(1):82-90. doi: 10.1097/MCC.0000000000000174.
2
Emerging therapies for the prevention of acute respiratory distress syndrome.预防急性呼吸窘迫综合征的新兴疗法。
Ther Adv Respir Dis. 2015 Aug;9(4):173-87. doi: 10.1177/1753465815585716. Epub 2015 May 22.
3
Fifty Years of Research in ARDS. Is Acute Respiratory Distress Syndrome a Preventable Disease?ARDS 研究五十年:急性呼吸窘迫综合征是否可防?
Am J Respir Crit Care Med. 2017 Mar 15;195(6):725-736. doi: 10.1164/rccm.201609-1767CI.
4
How to ventilate patients without acute respiratory distress syndrome?如何对非急性呼吸窘迫综合征患者进行通气?
Curr Opin Crit Care. 2015 Feb;21(1):65-73. doi: 10.1097/MCC.0000000000000165.
5
Acute respiratory distress syndrome: shifting the emphasis from treatment to prevention.急性呼吸窘迫综合征:将重点从治疗转向预防
Curr Opin Crit Care. 2016 Feb;22(1):21-37. doi: 10.1097/MCC.0000000000000275.
6
Intraoperative risk factors for acute respiratory distress syndrome in critically ill patients.危重症患者急性呼吸窘迫综合征的术中危险因素。
Anesth Analg. 2010 Aug;111(2):464-7. doi: 10.1213/ANE.0b013e3181d8a16a. Epub 2010 Apr 24.
7
Preventing ARDS: progress, promise, and pitfalls.预防急性呼吸窘迫综合征:进展、前景与困境
Chest. 2014 Oct;146(4):1102-1113. doi: 10.1378/chest.14-0555.
8
Early identification of patients with or at risk of acute lung injury.急性肺损伤患者或有急性肺损伤风险患者的早期识别。
Neth J Med. 2009 Oct;67(9):268-71.
9
Lung-protective ventilation initiated in the emergency department (LOV-ED): a study protocol for a quasi-experimental, before-after trial aimed at reducing pulmonary complications.急诊科启动的肺保护性通气(LOV-ED):一项旨在减少肺部并发症的前后对照准实验性研究方案
BMJ Open. 2016 Apr 11;6(4):e010991. doi: 10.1136/bmjopen-2015-010991.
10
Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients.一项前瞻性、多中心、随机、常规治疗对照、平行组试验的原理和设计,旨在评估乌司他丁预防高危患者急性呼吸窘迫综合征的疗效和安全性。
BMJ Open. 2019 Mar 7;9(3):e025523. doi: 10.1136/bmjopen-2018-025523.

引用本文的文献

1
A Case of Acute Respiratory Distress Syndrome Following Non-thoracic Trauma in a Patient With Idiopathic Pulmonary Fibrosis.一例特发性肺纤维化患者非胸部创伤后急性呼吸窘迫综合征病例
Cureus. 2024 Jun 29;16(6):e63467. doi: 10.7759/cureus.63467. eCollection 2024 Jun.
2
L-carnitine reduces acute lung injury via mitochondria modulation and inflammation control in pulmonary macrophages.左旋肉碱通过调节肺巨噬细胞中线粒体和控制炎症减轻急性肺损伤。
Braz J Med Biol Res. 2023 Oct 20;56:e12830. doi: 10.1590/1414-431X2023e12830. eCollection 2023.
3
Admission serum sodium and osmolarity are not associated with the occurrence or outcomes of acute respiratory distress syndrome in critically ill.

本文引用的文献

1
Association between tidal volume size, duration of ventilation, and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis.无急性呼吸窘迫综合征患者的潮气量大小、通气时间与镇静需求之间的关系:一项个体患者数据荟萃分析。
Intensive Care Med. 2014 Jul;40(7):950-7. doi: 10.1007/s00134-014-3318-4. Epub 2014 May 9.
2
Characteristics and outcomes of patients hospitalized following pulmonary aspiration.肺吸入后住院患者的特征与结局
Chest. 2014 Oct;146(4):899-907. doi: 10.1378/chest.13-3028.
3
Predicting risk of postoperative lung injury in high-risk surgical patients: a multicenter cohort study.
危重症患者入院时的血清钠和渗透压与急性呼吸窘迫综合征的发生或结局无关。
J Crit Care. 2023 Feb;73:154179. doi: 10.1016/j.jcrc.2022.154179. Epub 2022 Oct 28.
4
Prediction of Neonatal Respiratory Distress Biomarker Concentration by Application of Machine Learning to Mid-Infrared Spectra.应用机器学习对中红外光谱进行新生儿呼吸窘迫生物标志物浓度预测。
Sensors (Basel). 2022 Feb 23;22(5):1744. doi: 10.3390/s22051744.
5
Predicting acute respiratory distress syndrome in influenza pneumonia patients using delta mean platelet volume.利用血小板平均体积变化率预测流感肺炎患者的急性呼吸窘迫综合征。
BMC Pulm Med. 2021 Dec 7;21(1):405. doi: 10.1186/s12890-021-01763-5.
6
Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19?磷脂结合型超氧化物歧化酶的过去和现在:在当前的 COVID-19 大流行中有任何作用吗?
Biomed Pharmacother. 2021 Sep;141:111922. doi: 10.1016/j.biopha.2021.111922. Epub 2021 Jul 14.
7
Size-dependent anti-inflammatory activity of a peptide-gold nanoparticle hybrid in vitro and in a mouse model of acute lung injury.肽-金纳米粒子杂化物在体外和急性肺损伤小鼠模型中的尺寸依赖性抗炎活性。
Acta Biomater. 2019 Feb;85:203-217. doi: 10.1016/j.actbio.2018.12.046. Epub 2018 Dec 28.
8
[Interactions between lung and kidney in the critically ill].危重症患者肺与肾的相互作用
Med Klin Intensivmed Notfmed. 2018 Sep;113(6):448-455. doi: 10.1007/s00063-018-0472-4. Epub 2018 Aug 9.
9
PRactice of VENTilation in Middle-Income Countries (PRoVENT-iMIC): rationale and protocol for a prospective international multicentre observational study in intensive care units in Asia.中等收入国家通气实践(PRoVENT-iMIC):一项针对亚洲重症监护病房的前瞻性国际多中心观察性研究的原理与方案
BMJ Open. 2018 Apr 28;8(4):e020841. doi: 10.1136/bmjopen-2017-020841.
10
Early identification of patients at risk for acute respiratory distress syndrome among severe pneumonia: a retrospective cohort study.重症肺炎患者中急性呼吸窘迫综合征高危患者的早期识别:一项回顾性队列研究
J Thorac Dis. 2017 Oct;9(10):3979-3995. doi: 10.21037/jtd.2017.09.20.
预测高危手术患者术后肺部损伤风险:一项多中心队列研究。
Anesthesiology. 2014 May;120(5):1168-81. doi: 10.1097/ALN.0000000000000216.
4
The beta agonist lung injury trial prevention. A randomized controlled trial.β受体激动剂肺损伤试验预防。一项随机对照试验。
Am J Respir Crit Care Med. 2014 Mar 15;189(6):674-83. doi: 10.1164/rccm.201308-1549OC.
5
SpO2/FiO2 ratio on hospital admission is an indicator of early acute respiratory distress syndrome development among patients at risk.入院时的血氧饱和度/吸入氧浓度比值是高危患者早期急性呼吸窘迫综合征发生的一个指标。
J Intensive Care Med. 2015 May;30(4):209-16. doi: 10.1177/0885066613516411. Epub 2013 Dec 20.
6
Inhaled anticoagulation regimens for the treatment of smoke inhalation-associated acute lung injury: a systematic review.吸入性抗凝治疗烟雾吸入相关性急性肺损伤:系统评价。
Crit Care Med. 2014 Feb;42(2):413-9. doi: 10.1097/CCM.0b013e3182a645e5.
7
The role of potentially preventable hospital exposures in the development of acute respiratory distress syndrome: a population-based study.潜在可预防的医院暴露在急性呼吸窘迫综合征发展中的作用:基于人群的研究。
Crit Care Med. 2014 Jan;42(1):31-9. doi: 10.1097/CCM.0b013e318298a6db.
8
Emerging pharmacological therapies for prevention and early treatment of acute lung injury.急性肺损伤的预防和早期治疗的新兴药理学治疗方法。
Semin Respir Crit Care Med. 2013 Aug;34(4):448-58. doi: 10.1055/s-0033-1351118. Epub 2013 Aug 11.
9
Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation*.早期急性肺损伤:在需要正压通气之前识别肺损伤的标准*。
Crit Care Med. 2013 Aug;41(8):1929-37. doi: 10.1097/CCM.0b013e31828a3d99.
10
Prone positioning in severe acute respiratory distress syndrome.俯卧位通气治疗严重急性呼吸窘迫综合征。
N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20.